Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Strahlentherapie und Onkologie
Published in: Strahlentherapie und Onkologie 12/2018

01-12-2018 | Review Article

Health services research in German radiation oncology: new opportunities to advance cancer care

Authors: Daniel Medenwald, Christian T. Dietzel, Dirk Vordermark

Published in: Strahlentherapie und Onkologie | Issue 12/2018

Login to get access

Abstract

Background

Health services research (HSR) is of increasing relevance to scientists, health-care providers, and clinicians. Complex population-based secondary data are a key source of information for analyses of health-care effects in radiation oncology.

Methods

In this short paper, we examine potential applications of secondary data focusing on statistics from the diagnosis-related groups (DRG). This data set incorporating all hospitalized cases in Germany is based on claims of reimbursements and is provided by the Research Data Centers (RDC) of the Federal Statistical Office and the Statistical Offices of the federal states. A short outlook regarding other data sources is also presented.

Results

In radiation oncology, secondary data such as the DRG statistics have rarely been used to examine health-care effects, despite their great potential for reporting effects in a broad population-based setting. Furthermore, for most data sources, the application to use these data is accessible with minor effort. However, data concerning outpatient care are difficult to analyze on a comparable level.

Conclusion

DRG statistics and related secondary data provide a remarkable source of information for analyses of health-care-related effects in radiation oncology.
Literature
1.
Kaatsch P (2015) Krebs in Deutschland 2011/12. Robert Koch-Institut und Gesellschaft der epidemiologischenKrebsregister in Deutschland e. V., Berlin
2.
Delaney G, Jacob S, Featherstone C, Barton M (2005) The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104:1129–1137CrossRef
3.
Lievens Y, Grau C (2012) Health economics in radiation oncology: introducing the ESTRO HERO project. Radiother Oncol 103:109–112CrossRef
4.
Borras JM, Lievens Y, Barton M et al (2016) How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis. Radiother Oncol 119:5–11CrossRef
5.
Lievens Y, Defourny N, Coffey M et al (2014) Radiotherapy staffing in the European countries: final results from the ESTRO-HERO survey. Radiother Oncol 112:178–186CrossRef
6.
Lohr KN, Steinwachs DM (2002) Health services research: an evolving definition of the field. Health Serv Res 37:7–9PubMed
7.
8.
Glocker S, Loskamp N, Bamberg M, Roeder N (2006) Evaluation of flat-rate payment in radiation oncology. German experience with disease-related groups for inpatient funding in radiation oncology. Strahlenther Onkol 182:305–311CrossRef
9.
Wong K, Delaney GP, Barton MB (2016) Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand. Radiother Oncol 119:145–149CrossRef
10.
Schubert-Fritschle G, Combs SE, Kirchner T, Nüssler V, Engel J (2017) Use of multicenter data in a large cancer registry for evaluation of outcome and implementation of novel concepts. Front Oncol 7:234CrossRef
11.
Schmidberger H (2017) Reimbursement of radiotherapy in Germany. Cancer Radiother 21:544–546CrossRef
12.
Dasch B, Kalies H, Feddersen B, Ruderer C, Hiddemann W, Bausewein C (2017) Care of cancer patients at the end of life in a German university hospital: a retrospective observational study from 2014. PLoS ONE 12:e175124CrossRef
13.
Reinhold T, Dornquast C, Börgermann C, Weißbach L (2016) Treatment costs of localized prostate cancer in Germany: economic results from the HAROW observational study. Urologe A 55:1573–1585CrossRef
14.
Bekelman JE, Halpern SD, Blankart CR et al (2016) Comparison of site of death, health care utilization, and hospital expenditures for patients dying with cancer in 7 developed countries. JAMA 315:272–283CrossRef
15.
Berger B, Ankele H, Bamberg M, Zips D (2014) Patients who die during palliative radiotherapy. Status survey. Strahlenther Onkol 190:217–220CrossRef
16.
Frenzel T, Krull A (2015) The use of IMRT in Germany. Strahlenther Onkol 191:821–826CrossRef
17.
Marnitz S, Köhler C, Rauer A et al (2014) Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers. Strahlenther Onkol 190:34–40CrossRef
18.
Datta NR, Khan S, Marder D, Zwahlen D, Bodis S (2020) Radiotherapy infrastructure and human resources in Switzerland : present status and projected computations for. Strahlenther Onkol 2016(192):599–608
19.
Zurl B, Bayerl A, De Vries A et al (2018) ÖGRO survey on radiotherapy capacity in Austria: status quo and estimation of future demands. Strahlenther Onkol 194:284–292CrossRef
Metadata
Title
Health services research in German radiation oncology: new opportunities to advance cancer care
Authors
Daniel Medenwald
Christian T. Dietzel
Dirk Vordermark
Publication date
01-12-2018
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 12/2018
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-018-1357-4

Other articles of this Issue 12/2018

Strahlentherapie und Onkologie 12/2018 Go to the issue

Literatur kommentiert

Carboplatin verbessert nicht die Wirksamkeit der adjuvanten Radiotherapie bei fortgeschrittenen kutanen Plattenepithelkarzinomen der Kopf-Hals-Region

Original Article

Radiosurgery of vestibular schwannoma: prognostic factors for hearing outcome using 3D-constructive interference in steady state (3D-CISS)

Literatur kommentiert

Ist Operation und anschließende Radiochirurgie gleichwertig mit Operation und Ganzhirnbestrahlung erst im Rezidiv bezüglich Gesamtüberleben und intrazerebraler Tumorkontrolle bei Patienten mit 1–4 Hirnmetastasen?

Correction

Correction to: Prof. Dr. Luther W. Brady verstorben

Original Article

Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters

Literatur kommentiert

Die kapazitive Hyperthermie scheint das Schmerzansprechen bei der palliativen Bestrahlung von schmerzhaften Knochenmetastasen zu verbessern